To help stakeholders stay informed of the latest developments and gain insights into market trends, this article provides a systematic review and in-depth analysis of the cosmetic ingredient filings published by China’s National Medical Products Administration (NMPA) in November 2025. The report mainly covers the number of new ingredient filings during the month, basic information about the filing enterprises, the regional distribution of domestic filers, ingredients that have been filed multiple times, and interpretations of selected ingredients. It aims to offer valuable data support and information references for the cosmetics industry.

On 17 November 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued preliminary opinion (SCCS/1682/25) on Butylated Hydroxyanisole (BHA) (CAS No. 25013-16-5). The deadline for comments is set for 19 January, 2026.

In November 2025, the UK’s Scientific Advisory Group of Chemical Safety of Non-food and Non-medicinal Consumer Products (SAG-CS) issued an opinion on Hexyl Salicylate in Cosmetic Products.

To help stakeholders stay informed of the latest developments and gain insights into market trends, this article provides a systematic review and in-depth analysis of the cosmetic ingredient filings published by China’s National Medical Products Administration (NMPA) in October 2025. The report mainly covers the number of new ingredient filings during the month, basic information about the filing enterprises, the regional distribution of domestic filers, ingredients that have been filed multiple times, and interpretations of selected ingredients. It aims to offer valuable data support and information references for the cosmetics industry.

On November 6, 2025, Taiwan's Food and Drug Administration (TFDA) released the updated list of restricted cosmetic ingredients. The key revisions are as follows: Deletion of One Ingredient: The use of boric acid in cosmetics is completely banned. Boric acid and its salts, previously listed as restricted ingredients, have been removed from the list of restricted substances. Addition of 34 Ingredients: The total number of restricted ingredients has increased from 186 to 219, with 34 new substances added to the list of restricted cosmetic ingredients. Revision of 74 Entries: A total of 74 entries have been revised in the updated list of restricted cosmetic ingredients.

On 14 November, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued final opinion(SCCS/1681/25) on Tea Tree Oil (CAS/EC No. 68647-73-4 /285-377-1). Previously on 6 June, 2025, the SCCS issued scientific opinion(SCCS/1681/25) on Tea Tree Oil which has been open for comments. The final opinion issued this time is largely consistent with the opinion issued during the public consultation phase, but includes certain updates. These updates are highlighted in bold in the following text.

On June 6, 2025, CIRS Group officially launched the Global Cosmetic Ingredient Regulatory Database--Global CosIng. This database integrates regulatory information on cosmetic ingredients from major markets, including China (Taiwan included), the European Union, the United States, Canada, ASEAN countries, South Korea, and Japan. It is designed to provide enterprises with a one-stop, authoritative, and user-friendly platform for ingredient compliance inquiries, supporting cosmetic companies in global regulatory compliance and product development.

On October 30, 2025, China’s National Medical Products Administration (NMPA) approved two new cosmetic ingredients for registration – a major step forward in China’s cosmetic ingredient innovation. Details and analysis below.

On October 3, 2025, the National Agency of Drug and Food Control (BPOM) of Indonesia officially enacted the Technical Requirements for Cosmetic Ingredients (Regulation No. 25 of 2025), which comprehensively updates the usage standards for cosmetic ingredients. According to the regulatory provisions, the previously implemented Regulation No. 23 of 2019 and Regulation No. 17 of 2022 are simultaneously repealed.

To enhance the implementation of China’s Cosmetics Supervision and Administration Regulations and promote ingredient innovation, the National Medical Products Administration (NMPA) has released Announcement No. 61 of 2025. This update introduces a dynamic adjustment mechanism for the Inventory of Existing Cosmetic Ingredients (IECIC) – enabling continuous updates, improved accuracy, and better alignment with global cosmetic safety practices. The move marks a major step toward more transparent and science-driven cosmetic ingredient management in China. To clarify key management issues related to the IECIC, the NMPA has issued a series of official responses. The cosmetic team at CIRS Group has compiled and translated these explanations for industry reference.